Liposoma Health introduces a novel lipid-based concentrate for creatine stabilization, preserving its integrity without water or preservatives. This innovative delivery system ensures compatibility with various beverage formats, offering flexibility in dosing and maintaining creatine functionality.
Liposoma Health has developed an innovative lipid-based concentrate designed to stabilize creatine without the need for water or preservatives. This solution addresses the common challenge of creatine degradation in aqueous environments, particularly under thermal stress. By maintaining creatine in a water-free lipid matrix, this concentrate ensures preservation of creatine integrity, enabling its incorporation into a wide range of beverage formats. This approach offers flexibility in dosing and product design, allowing creatine to be added to beverages post-processing.
The core of this technology is a proprietary lipid-glycerol matrix that stabilizes creatine by avoiding exposure to water and thermal stress. Key features include:
This technology is at TRL 5, indicating that it has been validated in relevant environments with a patented platform already extensively developed and validated. The system requires only limited additional optimization for most applications, and Liposoma Health supports scaling through established manufacturing partners.
Liposoma is a biotechnology company based in Amsterdam, specializing in advanced liposomal and lipid-based formulations for research and industry, with a focus on drug delivery, nutraceuticals, and medical applications.